The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances. Talk of testosterone deficiency is hard to escape these days, with podcasters and politicians obsessing over how to avoid a "low T" lifestyle. As the hormone's cultural salience deepens, demand is growing. In a timely move, telehealth giant Hims just launched a testosterone replacement therapy service for cisgender men. The direct-to-consumer juggernaut will offer two types of injectable treatments, as well as an oral pill option that can be sent to patients after they take an at-home capillary blood test.

Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

WIRED tested samples of four types of peptides. The results show how lightly regulated the industry is, even as popularity surges. The Mr. Green bodega sits on a busy stretch of Bedford Avenue in Brooklyn, New York. Near the counter, you can buy the usual assortment of candy, gum, rolling papers, and soda. You can also purchase tiny vials of injectable peptides .

We earn a commission if you buy something through an affiliate link. Deepfakes are wrecking influencers' credibility, one fake ad at a time E arlier this year, Emily Schuman, the creator of the lifestyle blog Cupcakes and Cashmere, saw a photo of herself she didn't recognize on Instagram . In a sponsored ad, Schuman, who has more than 500,000 Instagram followers, is holding up a vial of GLP-1 drugs, advertising the telehealth company Gala. There was just one problem: Schuman had never heard of Gala and had nothing to do with the ad. The ad was based on a digitally altered version of a selfie Schuman had taken in her car and posted on Instagram years earlier.

How an alliance of tech startups, MAHA operatives, and actual medical experts made millennial women the new face of hormone therapy. Lisa Schrenk didn't know it yet, as she trudged down a dirt trail last August, but her life was about to change. She'd set out late the night before with her hiking group, scrambling up Virginia's Old Rag Mountain in darkness. They reached the peak in time to watch the sun rise over the Blue Ridge range. Afterward, the women snapped photos. In one, Schrenk gazes out over the horizon, her long dark hair pulled into a ponytail. The image is deceptively triumphant. In reality, she had been contemplating suicide. Schrenk, a longtime IT specialist for the federal government, had started setting aside belongings for friends and family, organizing her financial affairs, and clearing out her office.

For Ache Kodo, seeing a doctor once meant saving money for the journey. Living in Bitkine, in central Chad, she said a medical visit could mean paying for transport, the consultation and other costs of travelling to a larger town. Now, she can consult a doctor remotely through a Telemedan kiosk closer to home. "Telemedan changed how my family accessed healthcare services," Ache told Al Jazeera. "It was difficult before, as it involved me saving money to travel just to see a doctor. Now I'm able to do it on time with fewer costs from where I am. It has also enhanced my economic status."

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this author to personalize your feed and get instant alerts.

The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs. Has anyone tried to sell you peptides yet? Once a niche interest among bodybuilders and biohackers, peptides are an increasingly popular class of substance hyped by both fringe influencers and the current US Secretary of Health and Human Services. Earlier this year, Robert F. Kennedy Jr. told the podcaster Joe Rogan that the government intended to loosen restrictions on peptide production.

Welcome to the "Temu experience of telehealth," where everyone from Grindr to MAGA influencers can open a virtual clinic selling weight loss drugs and more. This May, the digital search company JustAnswer made an odd pivot: It started selling weight loss drugs. Launching an online pharmacy to peddle GLP-1s wasn't the obvious next step for a business that offers paid guidance from experts, but chief executive Andy Kurtzig says the decision was partly driven by advice from ChatGPT and partly by avid customer interest. The number of queries related to the drugs more than doubled between 2024 and 2025, he says. Plus, it was easy to find help: A company called WhiteLabelMD handles customer service, provides software, and connects patients with clinicians who prescribe drugs like semaglutide and tirzepatide.

Large language models (LLMs) are increasingly deployed in medical contexts, raising critical concerns about safety, alignment, and susceptibility to adversarial manipulation. While prior benchmarks assess model refusal capabilities for harmful prompts, they often lack clinical specificity, graded harmfulness levels, and coverage of jailbreak-style attacks. We introduce CARES (Clinical Adversarial Robustness and Evaluation of Safety), a benchmark for evaluating LLM safety in healthcare. CARES includes over 18,000 prompts spanning eight medical safety principles, four harm levels, and four prompting styles: direct, indirect, obfuscated, and role-play, to simulate both malicious and benign use cases.